Intellectual Property India Publishes Patent Application for Biologically Active Pharmaceutical Composition Targeting Wnt Receptors And Pharmaceutically Active Candidates Against Wnt Biocomplex

MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202443102451 A) filed by Transcell Oncologics Private Limited on December 24, 2024, for Biologically Active Pharmaceutical Composition Targeting Wnt Receptors And Pharmaceutically Active Candidates Against Wnt Biocomplex.

Inventor includes Subhadra Dravida.

The application for the patent was published on June 26, 2026, under issue no. 26/2026.

Abstract: A pharmaceutically active compound as a Wnt transcription inhibitor and a method thereof to inhibit the growth of tumors are disclosed. The pharmaceutically active compound comprises a plurality of small molecules and a macrocyclic/non-macrocyclic compound. The small molecules act as canonical Wnt si...